Find ONC206 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Onc206, 1638178-87-6, Ow6lm47pnk, Onc 206, 11-benzyl-7-[(2,4-difluorophenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one, 4-((2,4-difluorophenyl)methyl)-2,4,6,7,8,9-hexahydro-7-(phenylmethyl)imidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(1h)-one
Molecular Formula
C23H22F2N4O
Molecular Weight
408.4  g/mol
InChI Key
ITMGVSSHWMTJRR-UHFFFAOYSA-N
FDA UNII
OW6LM47PNK

ONC206
DRD2 Antagonist/ClpP Agonist ONC206 is an orally bioavailable, selective bitopic dopamine receptor D2 (DRD2) antagonist and mitochondrial caseinolytic protease P (ClpP) agonist, with potential antineoplastic activity. Upon administration, DRD2 antagonist/ClpP agonist ONC206 targets, binds to and inhibits the activity of DRD2. This may inactivate Akt (protein kinase B) and extracellular signal-regulated kinase (ERK), which may result in inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt signal transduction pathway as well as the mitogen-activated protein kinase (MAPK)/ERK-mediated pathway. This may lead to the induction of tumor cell apoptosis mediated by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)/death receptor type 5 (DR5; TRAIL receptor 2) signaling in tumor cells. In addition, ONC206 targets and binds to ClpP and induces proteolysis. This may disrupt mitochondrial structure and function in tumor cells and lead to tumor cell death. DRD2, a G protein-coupled receptor (GPCR), is overexpressed in various malignancies. It is activated by dopamine produced by the tumor cells or present in the tumor microenvironment (TME) and plays an important role in the pro-survival and stress signaling pathways. ONC206 is able to cross the blood-brain barrier (BBB).
1 2D Structure

ONC206

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
11-benzyl-7-[(2,4-difluorophenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one
2.1.2 InChI
InChI=1S/C23H22F2N4O/c24-18-7-6-17(20(25)12-18)14-29-22(30)19-15-27(13-16-4-2-1-3-5-16)10-8-21(19)28-11-9-26-23(28)29/h1-7,12H,8-11,13-15H2
2.1.3 InChI Key
ITMGVSSHWMTJRR-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
OW6LM47PNK
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Onc206

2. 11-benzyl-7-((2,4-difluorophenyl)methyl)-2,5,7,11-tetrazatricyclo(7.4.0.02,6)trideca-1(9),5-dien-8-one

2.3.2 Depositor-Supplied Synonyms

1. Onc206

2. 1638178-87-6

3. Ow6lm47pnk

4. Onc 206

5. 11-benzyl-7-[(2,4-difluorophenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one

6. 4-((2,4-difluorophenyl)methyl)-2,4,6,7,8,9-hexahydro-7-(phenylmethyl)imidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(1h)-one

7. 11-benzyl-7-((2,4-difluorophenyl)methyl)-2,5,7,11-tetrazatricyclo(7.4.0.02,6)trideca-1(9),5-dien-8-one

8. Refchem:168241

9. Drd2 Antagonist/clpp Agonist Onc206

10. Unii-ow6lm47pnk

11. 7-benzyl-4-(2,4-difluorobenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4h)-one

12. Orb1307929

13. Chembl4650311

14. Onc 206 [who-dd]

15. Schembl20464679

16. Schembl29538852

17. Onc-206, Onc206 Powder

18. Onc206?

19. Glxc-23355

20. Ex-a5759

21. Nqc17887

22. Nsc783746

23. S6853

24. Akos040742338

25. Nsc-783746

26. Da-76424

27. Ms-27016

28. Hy-135147

29. Cs-0109614

30. D87153

2.4 Create Date
2018-12-15
3 Chemical and Physical Properties
Molecular Weight 408.4 g/mol
Molecular Formula C23H22F2N4O
XLogP32.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area39.2
Heavy Atom Count30
Formal Charge0
Complexity733
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Looking for 1638178-87-6 / ONC206 API manufacturers, exporters & distributors?

ONC206 manufacturers, exporters & distributors 1

20

PharmaCompass offers a list of ONC206 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right ONC206 manufacturer or ONC206 supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred ONC206 manufacturer or ONC206 supplier.

API | Excipient name

ONC206

Synonyms

1638178-87-6, Ow6lm47pnk, Onc 206, 11-benzyl-7-[(2,4-difluorophenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one, 4-((2,4-difluorophenyl)methyl)-2,4,6,7,8,9-hexahydro-7-(phenylmethyl)imidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(1h)-one, 11-benzyl-7-((2,4-difluorophenyl)methyl)-2,5,7,11-tetrazatricyclo(7.4.0.02,6)trideca-1(9),5-dien-8-one

Cas Number

1638178-87-6

Unique Ingredient Identifier (UNII)

OW6LM47PNK

About ONC206

DRD2 Antagonist/ClpP Agonist ONC206 is an orally bioavailable, selective bitopic dopamine receptor D2 (DRD2) antagonist and mitochondrial caseinolytic protease P (ClpP) agonist, with potential antineoplastic activity. Upon administration, DRD2 antagonist/ClpP agonist ONC206 targets, binds to and inhibits the activity of DRD2. This may inactivate Akt (protein kinase B) and extracellular signal-regulated kinase (ERK), which may result in inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt signal transduction pathway as well as the mitogen-activated protein kinase (MAPK)/ERK-mediated pathway. This may lead to the induction of tumor cell apoptosis mediated by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)/death receptor type 5 (DR5; TRAIL receptor 2) signaling in tumor cells. In addition, ONC206 targets and binds to ClpP and induces proteolysis. This may disrupt mitochondrial structure and function in tumor cells and lead to tumor cell death. DRD2, a G protein-coupled receptor (GPCR), is overexpressed in various malignancies. It is activated by dopamine produced by the tumor cells or present in the tumor microenvironment (TME) and plays an important role in the pro-survival and stress signaling pathways. ONC206 is able to cross the blood-brain barrier (BBB).

ONC206 Manufacturers

A ONC206 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ONC206, including repackagers and relabelers. The FDA regulates ONC206 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ONC206 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

ONC206 Suppliers

A ONC206 supplier is an individual or a company that provides ONC206 active pharmaceutical ingredient (API) or ONC206 finished formulations upon request. The ONC206 suppliers may include ONC206 API manufacturers, exporters, distributors and traders.

ONC206 GMP

ONC206 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of ONC206 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right ONC206 GMP manufacturer or ONC206 GMP API supplier for your needs.

ONC206 CoA

A ONC206 CoA (Certificate of Analysis) is a formal document that attests to ONC206's compliance with ONC206 specifications and serves as a tool for batch-level quality control.

ONC206 CoA mostly includes findings from lab analyses of a specific batch. For each ONC206 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

ONC206 may be tested according to a variety of international standards, such as European Pharmacopoeia (ONC206 EP), ONC206 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ONC206 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty